Skip to main content
Eurostyle Collection Lisboa Table Lamp by Gilt <img src="https://chart.googleapis.com/chart?cht=qr&chs=200x200&chl=https%3A%2F%2Fapi.shopstyle.com%2Faction%2FapiVisitRetailer%3Fid%3D687775003%26pid%3Duid1456-40284116-11%26utm_content%3Dqr-code">

ALL ABOUT MS Symptoms of MS (Part 3)

Symptoms of the disease

Symptoms of MS are very diverse and numerous. In most patients, symptoms occur occasionally and progression of the disease can be altered both in its intensity and duration. They depend on the part of the brain and spinal cord affected by the disease. Not all patients have the same symptoms, they vary from one person to another, but vary with each patient over time. A person suffering from MS will usually experience more than one symptom, but never everything. Symptoms may occur individually or in combination and last for a few weeks to a few months after reporting.
The initial symptoms of MS in the order of frequency are: subjective sensory impairment, reduced visual acuity, loss of strength in one or more limbs, duplicate images, balance disorders and vertigo and sphincter disorders.

The most common symptoms of MS are: feeling sick (hypoesthesia), muscle weakness, painful muscle spasms, difficulty in movement, coordination and balance problems (ataxia), speech problems (disartia) or swallowing (dysphagia), visual impairment, disorders of the sphincter, sexual problems, acute or chronic pain, and cognitive and emotional disorders. The common symptom of MS is spasticity, a condition in which the muscles of opposite functions are simultaneously contracted or relaxed, and are due to increased muscle tone (tension).

Turn off the feelings


They are very common and in MS occur relatively early. There are frequent paraesthesia (feelings of tiredness, rupture, tingling), dizesthesia (unpleasant sensations, usually painful, caused by the action of an irritant that does not normally cause such a feeling - eg, the patient touches the pain as a pain), hyperpathy (increased sensitivity to painful irritation) and anesthesia (complete loss of any feeling including pain, touch and temperature).

Visual disturbance

Visual disturbances are also very common symptoms, with 30% of patients reporting the first symptom of the disease. Visual disturbances are usually unilateral, of varying duration and accompanied by complete visual recovery. They are most commonly due to inflammation and demyelinization of the optic nerve (so-called optic neuritis) and then treated with corticosteroids in the form of three-day pulse therapy. The patient usually complains of pain in the depth of the eye or in the forehead and in the blurred vision, especially at dusk; Colors are often made "washed".

Due to the weakness of the muscles that trigger the eyeball, diplopia (i.e., double images) may appear. In this case, a patch covering one eye is sometimes used. However, ophthalmologists advise that their use be reduced to the minimum, eg. only in reading or driving a car, because the brain will eventually learn to interpret two images accurately as one, but this process will be slower if the patch is used too often.
Sometimes a blind spot may occur in the area of ​​the clearest sight. Often there is also nystagmus - reluctant rapid movements of the eyeballs.

Like other MS symptoms, visual impairment may be exacerbated by stress, during infections, in conditions of increased body temperature, or by taking some medications (eg Tricyclic antidepressants).

Comments

Popular posts from this blog

ALL ABOUT MS Treatment (Part 9)

ALL ABOUT MS  Treatment (Part 9) Glatiramer acetate (Copaxone) This drug has similar effects and indications as interferon beta but a slightly different mechanism of action. It is applied at a dose of 20 mg, daily, subcutaneously. Side effects are also somewhat different, and include skin changes at the drug site and transient and short-term feeling of tightness in the chest with heart palpitations and a sense of lack of air. Natalizumab (Tysabri) This medicine is administered intravenously once a month. It works by preventing the immune system's entry into the brain and thus reducing the inflammatory (inflammatory) effect of immune cells on the nerve cells. Clinical trials have shown that natalizumab significantly reduces the incidence of attacks in the relapse form of MS, but in three patients it has caused a rare, but often fatal, brain disease. After this, the drug was withdrawn from the market, but in 2006 it was returned because of its positive effects o...

ALL ABOUT MS Treatment (Part 8)

Treatment Since research has shown that MS is an autoimmune disease, two basic approaches, immunosuppression (weakening of the immune response of the organism) and immunomodulation (changing the immune response) are used in the treatment. Numerous studies have shown that in the treatment of MS, the following drugs have success: interferon beta (betaferon, rebif, avonex), glatiramer acetate (copaxone), natalizumab (tysabri), mitoxantrone (novantrone) and some other cytostatics. Interferon beta Interferon beta is a protein that is a natural component of the human organism and is created by the cells of our immune system during defense reactions to external agents, primarily viruses. However, the most important effect this protein has is the so-called. Immunomodulatory effect: interferon beta promotes processes that mitigate the effects and slow down the ankle of multiple sclerosis, while the opposite inhibits it. The exact mechanism by which the interferon beta acts the...

ALL ABOUT MS Symptoms of MS (Part 4)

Urinary disorders About one-third of patients have sphincter disorders: an overwhelming need for urinary incontinence, which can sometimes be accompanied by frequent urination (so-called polacizuria), difficulty in urinating, retention (complete inability to urinate) and incontinence (loss of control over the process urinating, so that the urinary bladder empties reluctantly and unexpectedly). Urinary disorders can be accompanied by constipation and incontinence of the stool and impotence. Urinary disorders are very disturbing disorders, which significantly affect the quality of life, personal, professional and social functioning of the patients. Urinary disorders in MS are very common and occur in approximately 96% of patients with MS after 10 years of illness. Urinary disorders can occur at any time during the course of the disease, even at its inception (in about 2% of patients). Some researchers believe that patients in whom the disease begins with problems in the...